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R A D I A T I O N R E S E A R C H 84, 173-188 (1980) 
Nonparametric Representation of Dose-Effect Relations1 
A. M . K E L L E R E R A N D D. C H M E L E V S K Y 
Institut für Medizinische Strahlenkunde der Universität Würzburg, Versbacher Strasse 5, 
Würzburg D-8700, Germany 
A N D 
E . J . H A L L 
Radiological Research Laboratories, Columbia University, New York, New York 10027 
K E L L E R E R , A. M. , C H M E L E V S K Y , D . , A N D H A L L , E . J . Nonparametric Representation of 
Dose-Effect Relations. Radiär. Res. 84, 173-188 (1980). 
A method is described that permits a least-squares fit of survival data without invoking 
analytical expressions for the survival curve. As a more general constraint, applicable to a 
broad range of experimental data, convexity (from above) in the semilogarithmic repre-
sentation is utilized. The application of the method to individual survival curves is illustrated 
by a numerical example. The actual purpose of the method is, however, the analysis of sets of 
survival curves that differ by dose-modifying factors. The need for such joint fits arises, for 
example, in the biological intercomparison of neutron beams for radiotherapy, or in the 
determination of the oxygen enhancement ratio. It is exemplified here in the application of 
the method to a set of repeated survival experiments for hamster cells exposed to X rays. The 
method provides an estimated theoretical survival curve that is based on the total set of data, 
and it also yields a set of dose-modifying factors that represent deviations from the ideal 
curve in the individual experiments. 
I N T R O D U C T I O N 
The representation of observed dose-effect relations by analytical expressions 
is often a suitable method to verify or reject models of radiation action. In 
certain instances, however, it introduces an undesirable bias into the experimental 
data, and a method of curve fitting that is more flexible than the analytical repre-
sentation, but less arbitrary than a simple visual fit to the data points, is then de-
sirable. Such a method will be described. 
For simplicity the discussion will refer to survival curves of irradiated cells, but it 
will be evident that the considerations apply to dose-effect relations in general, or 
even to other relations such as the dependence of observed effects on time. 
The method wil l first be exemplified by its application to individual survival 
curves. However, individual survival curves wi l l usually not necessitate sophisti-
cated methods of fitting the data. Application of the method to individual survival 
1 Work supported by Euratom Contract 208-76-7 BIO D and by U . S. Department of Energy Con-
tract EP-78-S-02-4733. 
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curves is therefore of less practical importance than the simultaneous fit of sets of 
survival curves that differ by dose-modifying factors. 
C O N D I T I O N S F O R C U R V E F I T T I N G 
The Least-Squares Criterion 
Curve fitting is the determination of a theoretical survival function S(D) that is 
in "closest agreement'' with observed data. The observed data are survival levels 
Si experimentally obtained at different dosesD t (/ = 1, 2, . . . , / ) . One or more of 
these doses may be zero; i.e., the corresponding observations may be controls. I t 
wil l be assumed that the doses are arranged in ascending order (Di+l > Dt). 
The notion of closest agreement can be formulated in terms of different criteria, 
the two most suitable being the maximum likelihood and the least-squares criterion. 
The least-squares criterion only wi l l be utilized here. In the case of survival curves 
based on sufficient numbers of surviving colonies, the two criteria are asymptot-
ically equivalent. The maximum likelihood criterion is considered in Appendix B. 
It wi l l be practical to refer to the logarithm of survival rather than to survival, and 
appropriate abbreviations wi l l therefore be used. The logarithms of the observed 
survivals are designated 
/, = In 5, ( i = 1,2, . . . , / ) . (1) 
The corresponding theoretical estimates of the logarithms of survival resulting from 
the curve-fitting procedure are designated 
Tt = In Si9 (2) 
where 5, is an abbreviation for the estimated survival at dose Dt. 
For brevity tt and Tt wi l l be called observed and theoretical survival levels, while 
in fact they are the logarithms of the observed and estimated survival levels. 
The symbol at wi l l stand for the estimated standard error of the logarithm of 
survival at dose Dt. In Appendix A the relation between the variances of of the 
logarithms and the variances of the linear survival ratios is given. 
With these abbreviations, the least-squares condition is 
i (Tt - tdVaf = <t>(Tf) = M i n ; (3) 
t=i 
i.e., one must ask for those values T( that minimize the function </>(T/)-
Equation (3) involves the estimated survivals Tt at the dose values Dt. Only the 
array Tt(i = 1,2,. . . , / ) of estimated survival levels wi l l therefore be derived, and 
not the complete function T(D). Provided the number of data points is not too small, 
the set of estimated survival values Tt (/ = 1, 2, . . . , / ) wi l l determine the 
other values T(D) closely; even a simple polygon through the estimated points wi l l 
then be an adequate representation of the whole survival curve. The least-squares 
condition is meaningful only i f one excludes the trivial solution Tt = th This solu-
tion is usually unacceptable since it does not lead to a "smooth" curve. Certain 
restrictions must therefore be applied to the possible values T( to ensure a 
smooth curve. 
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The common method of introducing such constraints is the assumption of a 
specified analytical expression for T(D). Examples are a linear-quadratic expres-
sion in D or the well-known, more complicated relation that derives from the so-
called multitarget equation. By the choice of an analytical expression the possible 
sets of values T, are restricted, and the degree of restriction depends on the type of 
the equation that is chosen. I f the equation contains only one or two free parameters 
it can often provide a meaningful test of a model that corresponds to the equation. 
I f more free parameters are involved, most observed survival data can be ap-
proximated, and a fit cannot be interpreted as confirmation of the particular model 
underlying the equations. Instead the fit is merely an approximation of the actual 
survival curve that may be utilized for comparison of data obtained under different 
conditions. In this case it is more desirable to avoid the use of analytical expres-
sions altogether to eliminate the bias that is caused by the choice of such expressions. 
The question then arises: How can suitable constraints for the possible sets of 
values Tj be formulated? Furthermore, i f such constraints are found, a mathe-
matical procedure will be required that permits the determination of those values 
Tj (i = 1 , 2 , . . . , / ) that minimize Eq. (3) while satisfying the constraints. These 
problems wil l be considered. 
Constraints 
Suitable constraints must ensure that the survival curve, without being restricted 
by some analytical expression, wi l l nevertheless have essential properties that are 
common to most of the equations utilized to fit survival data. 
A very general property of such equations is monotonia decrease of with dose: 
Ti+l - T, < 0 (/ = 1, 2, . . . (4) 
However, this condition is not sufficient, as it wil l not, in general, guarantee a 
smooth curve. Therefore it wi l l not be considered further. Another property that 
is common to most survival equations is convexity (from above) 2 in the usual semi-
logarithmic plot. This is expressed by the following 1 - 2 constraints C }: 
Ct = - Di+l)T, - (Di+2 - D()Ti+l + (Di+l - DdTM < 0 
(/ = 1, 2, . . . , / - 2). (5) 
These constraints are a suitable basis for the numerical fitting of a majority of sur-
vival curves. I t is evident that there are data that fit neither the classical dose-ef-
fect equations nor the more general constraint of convexity. Modifications of Eq. 
(5) that allow for a shallow tail of a dose-effect relation, as may result from an 
hypoxic fraction of cells, may then be required. 
After the choice of a suitable set of constraints the problem of curve fitting is 
reduced to finding among all possible sets T{(i = 1,2,. . . , / ) the set of values that 
minimizes the least-squares function <t>(Ti). This is a nonlinear optimization problem 
that can be solved with established numerical techniques. 
2 This somewhat arbitrary term is used for brevity. It signifies negative or vanishing curvature of the 
function In 5(D); i.e., the area under the function In 5(D) is convex. 
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Computational Procedure 
Equation (3), together with a set of constraints such as Eq. (5), can be solved by 
established numerical procedures such as the method of steepest descent (4). These 
are numerical iteration procedures that search for extrema of a function </> (T (). The 
function need not be linear in the variables Tu and only such variables Tx are chosen 
that meet the constraints. 
General purpose computer versions of such algorithms exist ( / , 7-9) . In their 
typical form these algorithms require four subroutines that have to be provided by 
the user. One of these computes the so-called economical function 4> (T t) for a given 
set of values Tt (i = 1,2,. . . , / ) . Another subroutine computes the partial deriva-
tives d4>/dTi of the economical function. A further subroutine computes the con-
straints C-, and a last subroutine calculates the partial derivatives dCtldTk of the 
constraints. The relations that correspond to Eqs. (3) and (5) are listed in Appendix 
C to facilitate the actual use of the method. 3 
In addition, an initial set of estimated values J,- (/ = 1, 2 , . . . , I) is required as a 
starting point for the algorithm. We encountered no convergence difficulties asso-
ciated with starting points. 
Numerical Example 
Figure 1 illustrates the method by its application to a classical radiobiological 
study, namely, the survival data obtained by McCulloch and Ti l l (6) for mouse mar-
row cells irradiated in vivo. The vertical bars represent observed survival ratios 
with their standard errors; the open circles correspond to the least-squares solu-
tion Tt (i = 1, 2, . . . , / ) . The ordinate is normalized to Tu i.e., to the theoretical 
value that belongs to the controls. This theoretical value need not coincide with the 
observed survival ratio tx for the controls. The difference is, however, frequently 
insignificant because most experiments utilize a considerable number of control 
dishes, and the statistical weight of the observation is therefore large enough to 
bring the theoretical estimate close to the observed control value. 
The curve in Fig. 1 is drawn by hand through the set of estimated theoretical 
values Tj (i = 1 , 2 , . . . , / ) , i.e., through the open circles. It is evident that this 
leaves little freedom for interpolation, so that the estimated survival curve is well 
defined. 
The result of the nonparametric fit shows substantial curvature even at higher 
doses, while in the original publication the curve was drawn as a nearly straight line. 
Consistent with this difference the present analysis indicates an extrapolation 
number in excess of 3, while the original publication indicated a value of only 1.5. 
The present example demonstrates that the nonparametric fit can be useful even in 
its application to individual survival curves. The main purpose of the method is, 
however, the joint analysis of a group of similar survival curves; this wi l l be 
treated next. 
3 The standard version of our program utilizes the computer algorithm G R G A developed by Abadie 
( /) for general purpose application. Other algorithms (7-9) can be used alternatively. 
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F I G . 1. Gamma-ray survival curve obtained by McCulloch and Till (6) for the colony-forming ability 
of mouse marrow cells irradiated in vivo. The data are given as solid circles, their standard deviations as 
vertical bars. The solid line represents the nonparametric fit obtained by interpolation from the 
theoretical values (open circles) that result from the fitting procedure. Most of the data had been ob-
tained by irradiation after injection into the recipient mice. A few data points had been obtained by 
irradiation in situ in the femurs of living donor mice; if these latter points are disregarded, one ob-
tains nearly the same theoretical curve. 
J O I N T F I T O F S E V E R A L S U R V I V A L C U R V E S 
Computational Procedure 
There are situations where, in one experimental investigation, several dose-ef-
fect relations are obtained that are assumed to differ only by constant dose-
modifying factors. An example is the comparison of survival curves obtained with 
different high-energy neutron beams for therapy (2). The differences between such 
survival curves are of the order of a few percent. I t may then not be feasible to 
resolve the dependence of the relative biological effectiveness of two such beams 
on dose; instead the difference in effectiveness is approximated by a constant 
dose-modifying factor assigned to each curve. A similar situation applies i f slightly 
different dose-effect relations are obtained at varying positions within a phantom. 
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Another example is the determination of the oxygen enhancement ratio (OER). I t 
is probable that the OER depends on absorbed dose, but in most investigations it 
will be impossible to resolve any dose dependence of OER. It may then be a satis-
factory approximation to treat the OER as a constant dose-modifying factor. 
The simultaneous nonparametric fit of several dose-effect relations that differ 
by dose-modifying factors wi l l be considered in the following. The principles 
are the same as in the fitting of individual survival curves, but the technical details 
of the calculation are different and somewhat more complicated. 
As in the previous section, logarithmic survival levels are considered. The 
index / (/ = 1, 2, . . . , Ik) refers again to the different doses applied in one set 
of irradiations that establishes one survival curve. The index A' (k = 1, . . . , K) 
stands for the number of the survival curve. For brevity k is termed the number 
of the experiment; i.e., the totality of data obtained in the experimental investiga-
tion is said to consist of K experiments, each of these experiments establishing 
one dose-effect relation. With this convention tik stands for the data point / in 
experiment A-. Accordingly, tik is the logarithm of the number of viable colonies per 
plated cell at dose Dik. The corresponding standard deviation is aik. 
The dose-modifying factors wi l l be designated byfk, and fkDik wi l l be called the 
effective dose. Since the/A. are relative factors, one may first set/j = 1 and subse-
quently renormalize the values//,, relative to their average. The objective of the 
fitting procedure consists of finding dose-modifying factors and the dose-effect 
relation T(D) that minimize the sum of the squared deviations: 
2 {T(fk-Dik) - tikfl<j% = <f> = M i n . (6) 
ik 
In analogy to the procedure described in the preceding section one could derive, 
in addition to the factors fk, all theoretical values T(fk-Dik). However, this is im-
practical i f a considerable number K of experiments are to be fitted simultaneously. 
A modified method is therefore more convenient, where theoretical survival 
levels are estimated for a preselected, equidistant grid of values of the effective 
dose, and where the squares of the deviations are calculated on the basis of values 
T(fk-Dik) obtained by linear interpolation between the grid points. 
In the present context it is sufficient to outline the essentials of the mathematical 
procedure. For the actual numerical execution one can utilize the formulas listed in 
Appendix D. 
The variables which wi l l be optimized are the theoretical survival levels on an 
equidistant grid n • A (n = 0, 1, 2, . . . , N) of effective doses that are multiples 
of a convenient increment in dose, such as A = 1 or 0.5 Gy. 
The variables obtained in the optimization procedure are the values Tn (n = 1, 
. . . , N) at the grid points and the dose-modifying factors fk (k = 2, . . . , K). 
This is the situation where the same survival level (plating efficiency) results for 
unirradiated controls (D = 0) in the different experiments. In certain experiments 
(OER determinations) the conditions for the controls are not the same. In these 
cases one will have to include survival-modifying factors, i.e., vertical shifts for the 
individual survival curves. These are then additional variables in the optimization 
procedure; they are considered in the formulas in Appendix D. In practice the 
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F I G . 2. A series of independently established X-ray survival curves for V-79 hamster cells (5). The 
data are given as solid dots, their standard deviations as vertical bars. The joint nonparametric fit 
results in the solid curves. The dose-modifying factors which are a measure for the relative sensitivity 
of the cells are given on the lower left corner of the panels. The number of the experiment is given in the 
upper right corner. The experiments have been performed over a period of several months concurrently 
with neutron experiments. The numbering corresponds to the order of the curves given in Table III of the 
earlier analysis (5). The estimated theoretical survivals on the equidistant grid of doses are indicated 
by a series of open circles for experiments 3 and 8. Furthermore, the average survival curve (dose-
modifying factor 1) is added as a broken line for these two experiments. 
vertical shift factors are usually of minor importance as they are close to unity after 
each curve is normalized to its own control. 
Numerical Example 
The nonparametric curve-fitting procedure wi l l be exemplified here by its ap-
plication to 10 sets of repeated X-ray survival data for V-79 hamster cells. These 
data were obtained by Hall et al. (3) as concurrent control observations in an 
investigation of the effectiveness of neutrons of different energies. The experiments 
with various neutron energies had to be spread over a period of several months; 
accordingly, it was judged desirable to determine simultaneously with each neu-
tron experiment X-ray survival data that could indicate possible fluctuations in 
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T A B L E I 
Dose-Modifying Factors and Their 95% Confidence Ranges for 10 X-Ray Survival Curves (see Fig. 2) 
and Comparison with the Results from an Earlier Analysis (5) 
Dose-modifying factors 
Number of /* 
experiment 95% Confidence From earlier 
(k) fk range analysis (5) 
1 0.944 0.930-0.957 0.95 
2 0.932 0.908-0.958 0.94 
3 0.898 0.870-0.925 0.90 
4 1.002 0.979-1.020 1.01 
5 0.995 0.963-1.032 0.99 
6 0.961 0.938-0.982 0.96 
7 1.044 1.023-1.061 1.06 
8 1.095 1.078-1.111 1.065 
9 1.067 1.038-1.095 1.075 
10 1.067 1.049-1.091 1.05 
the sensitivity of the cells. Such fluctuations from experiment to experiment have 
indeed been found, and in an earlier analysis of these data (5) it was concluded that 
they correspond to dose-modifying factors in the approximate range of 0.94 to 
1.06. The earlier analysis was based on the determination of the mean inactivation 
dose for each survival curve, i.e., on one numerical parameter for each curve. I t is 
therefore of interest to examine whether a joint nonparametric fit of the set of 
curves leads to results consistent with those of the earlier analysis, and whether one 
idealized survival curve together with the set of modifying factors can adequately 
represent the data. 
Figure 2 gives the results of the joint fit of all 10 X-ray survival curves. The 
vertical bars represent the observed data and their standard deviations. The solid 
curves result from the ideal survival curve by dividing the abscissa values by the 
dose-modifying factor. Although this is somewhat arbitrary, the curves are plotted 
so that the observed controls lie on the origin; accordingly, the theoretical curves 
need not pass exactly through this point. However, the vertical shifts are so small 
that in most cases the theoretical curves pass virtually through the control values. 
As pointed out previously, the estimated curves are obtained by an interpola-
tion of the estimated survivals on an equidistant grid of doses. For experiments 3 
and 8 this grid of estimated survivals is indicated as a series of open dots for a grid 
distance A = 1 Gy. Computations with a finer grid of A = 0.5 Gy lead to no ap-
preciable changes in the numerical results. I t wi l l be noted that the estimated curve 
is closely determined even by grid points with A = 1 Gy. A degree of uncertainty 
remains in the initial slope of the curves, but any precise value of the initial 
slope would be a mathematical artifact in this experiment that includes no doses 
below 2 Gy. 
The dose-modifying factors that result from the analysis are a measure of the 
relative sensitivity of the cells; these factors are listed on the bottom left corner 
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F I G . 3. The data from Fig. 2 rescaled according to the dose-modifying factors. The solid curve is the 
theoretical survival curve that results from the nonparametric fit; it corresponds to the broken lines 
in Fig. 2. 
of each panel. The factors differ appreciably. As indicated in Table I they are con-
sistent with the values obtained in the earlier analysis (5). 
The derivation of confidence limits for the estimated survival curves is problem-
atical, because it is not clear how many degrees of freedom can be assigned to the 
fitting procedure if, in fact, the notion of degrees of freedom is applicable at all. 
This wi l l require further study. However, confidence limits are given in Table I for 
the dose-modifying factors, i.e., for the actual values of interest. Their derivation 
is explained in Appendix E. 
The approximation of all observations by an ideal curve adjusted by dose-
modifying factors is, judged from Fig. 2, consistent with the data. A somewhat 
more direct indication of the overall fit is afforded by Fig. 3, which gives the 
estimated ideal curve together with all data in a plot where the data are adjusted by 
the modifying factors; in this plot the abscissa is not the absorbed dose but the 
effective dose, i.e., the absorbed dose multiplied by the dose-modifying factor. For 
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F I G . 4. The uncorrected data from Fig. 2 fitted to one survival curve without dose-modifying factors. 
clarity of representation, data points belonging to the different experiments are not 
distinguished. However, even in the simplified representation one recognizes that 
the overall fit is adequate and that possible differences in the shape of the survival 
curves must be minor. 
The analysis supports the earlier conclusion that sizable fluctuations of sensi-
t ivi ty occur when survival curves are taken in separate experiments under seem-
ingly identical conditions. The cause of these variations has not been identified, but 
their presence clearly indicates the possible influence of interexperimental varia-
tions in experimental studies that involve the comparison of survival curves. The 
curve in Fig. 3 can be considered the best estimate of the ideal survival curve for 
V-79 hamster cells exposed to X rays. I t has the advantage of being based on the 
total information from all 10 experiments and of not being biased by the assumption 
of any particular analytical formula. However, the estimated curve is reliable only 
for the range of doses with actual observations. The extrapolation to other doses 
must remain arbitrary. In particular, one can make no definite statement on the 
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precise value of the initial slope of the curve, as no data were obtained for doses 
below 2 Gy. On the other hand, one can readily identify a range of possible values 
of the initial slope. 
Figure 4 gives, for comparison, the data in the original form without dose-
modifying factors. This corresponds to a straightforward superposition of all data. 
The solid curve is the nonparametric fit that results when all data are considered 
as part of one single experiment. The resulting curve is, in this particular case, 
similar to the curve obtained by the more sophisticated fitting procedure. Neverthe-
less, there are differences between the two resulting curves; thus the curve in Fig. 
4 is nearly straight at large doses, while the curve in Fig. 3 continues to bend over. 
The example of a set of relatively well defined X-ray survival curves has been 
considered here because unavoidable fluctuations in the repeated determination of 
a survival curve are a problem of considerable radiobiological interest, and it 
seemed desirable to reexamine the result of the earlier analysis. However, as 
pointed out, the method of nonparametric curve fitting may be of still greater 
importance i f one deals with poorly defined survival curves, i.e., with greater sta-
tistical errors. In such cases an objective algorithm wil l be required because any 
curve fitting by hand could be highly arbitrary. 
C O N C L U S I O N 
The numerical method that has been described permits the construction of 
theoretical survival curves from experimental data without the need of postulating 
analytical expressions that are assumed to fit the data. A simpler and more general 
condition, such as convexity (from above) in the semilogarithmic representa-
tion, is sufficient. 
The method is readily applicable to individual survival curves, or other dose-ef-
fect relations. I t can be of special value in those cases where it is desirable to repre-
sent a series of slightly differing survival curves by one common theoretical curve 
and a set of dose-modifying factors. 
A P P E N D I X E S 
A. Relation between the Standard Deviation of the Survival and the Standard 
Deviation of the Logarithm of Survival 
The standard error as of a survival ratio experimentally obtained at a certain 
dose can be estimated in the usual way. I f / vials are exposed, i f these yield 
the survivals (/ = 1, 2, . . . , / ) , and i f s is the mean of st then 
I f only one vial is exposed one must set s equal to the observed value s, and 
one can estimate the standard deviation on the basis of Poisson statistics. I f N is 
the estimated number of plated cells and n is the number of viable colonies then 
(A2) 
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With s = n/N one therefore obtains 
a2 = s2in. (A3) 
The Standard deviations estimated on the basis of Poisson statistics are some-
what smaller than the actual deviations that may partly be due to factors other 
than the limited cell number. In one experimental investigation (5), where a com-
parison of the two standard deviations has been performed, the difference was 
less than 20%. 
The standard error of the logarithm of survival can be linked to the standard 
error of survival. This can be seen in the following way: 
a'f = (In (s) - In (s))2. (A4) 
I f the fluctuations are small (|(.s - s)/s\ < 1) one has the approximate relation 
In (s) - In (s) « In (sis) ~ (s - s)/s. (A5) 
Therefore 
af « (s - s)2/s2 = a2sls2. (A6) 
Alternatively one can estimate a2 directly from the values tt (/ = 1, 2, . . . , / ) 
obtained for N vials that are exposed to the same dose. 
I f the standard deviation is estimated on the basis of Poisson statistics one 
obtains [see Eqs. (A3) and (A6)] 
o-2 « 0 - 2 / 5 2 = ( A 7 ) 
i.e., the estimated standard deviation of the logarithm of survival is equal to the 
inverse square root of the number of viable colonies. 
B. Maximum Likelihood and Least-Squares Criterion 
In cell survival experiments one usually deals with large numbers of plated 
cells and large numbers of viable colonies. In other experiments, however, the 
number of irradiated units per dose and/or the number of units that show the 
effect can be small. Induction of certain mutations or cell transformations, or 
survival studies on higher animals are examples. In these cases the least-squares 
criterion may not be valid; one can instead use the maximum likelihood con-
dition. Let Nj be the number of irradiated units at dose Dh and /?, the number 
of units that show the effect. Furthermore let 5, be the theoretical probability 
that an irradiated unit wi l l not show the effect at dose Dh The maximum likeli-
hood condition is then 
L = II ~ StY'Si*-"' = Max. (A8) 
This is equivalent to the condition 
</> = - 1 (rii In (1 - St) + (N, - nd In (5,-)) = Min ; (A9) 
i 
<t> can be used as the economical function in the optimization procedure. 
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I f the number of exposed units is large while the number of affected units is 
small, one can use Poisson probabilities instead of binomial probabilities. Instead 
of Eq. (A8) one then obtains 
L = I] e"ll'SlWi(\ - SiYW/ntl = Max. (A10) 
i 
The economical function can therefore be chosen as 
4> = - I (rii In (1 - St) + Ni-Sd = Min . ( A l l ) 
i 
I f the number of affected units is large, the maximum likelihood condition 
reduces to the least-squares criterion. This can be seen in the following way. 
I f the number of unaffected as well as the number of affected units is large, 
one can write the maximum likelihood condition in terms of normal distributions: 
L = n • *-<«-*> 8 'M. (A12) 
i <Ti(2ir)m 
This is equivalent to the least-squares criterion for the survivals: 
ct> = 1 (Si - 5 , ) 2 K = Min . (A13) 
i 
The least-squares criterion for the survivals is equivalent to that for the logarithms 
of the survivals, provided the relative fluctuations are small (\(s - s)/s\ < 1). 
In this case one has 
(st - Sd/Si = In (st) - In (St) (A14) 
and accordingly, i f 5, is set equal to s in Eq. (A6): 
k _ (Si - Si)2 (In (st) - In (St))2 v (t( - Tt)2 
0 = 2 ; = ; = 2 z = M m . (A15) 
C. Formulas for the Subroutines that are Required for Fitting a Survival Curve 
The formula for the economical function <j>(Ti) is given in Eq. (3). The formula 
for the constraints d is given in Eq. (5). The partial derivatives of the economical 
function are 
= 2 £ (Tt - tdlvl (A16) 
The partial derivatives of the constraints are 
dd/dTk = Di+2 - Di+1 for k = i 
= -Di+2 + Dt fork = i 4- 1 A 1 
= Di+l - Dt for k = i + 2 
= 0 otherwise. 
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D. Equations for the Subroutines in the Joint Fitting of Survival Curves that 
Differ by Dose-Modifying Factors 
It is assumed that the survival curves k (k = 1, 2, . . . , K) differ by dose-
modifying factors fk. The theoretical function, logarithm of survival, T(d), that 
depends on the ''effective dose", d, is to be estimated on the basis of the experi-
mental data. The effective dose, d, takes the valuesf k-D i k . The optimization pro-
cedure determines the values Tn of the function T(d) on the equidistant grid of 
values d - n • A (/? = 0, 1, . . . , N). In survival studies a suitable value for A wi l l 
usually be between 0.1 and 1 Gy, and usually N need not be larger than 50. 
Values of T(d) for arguments d not on the grid points are obtained by linear 
interpolation between the values Tn = 7 ( « A ) . 
The N values Tn and the K dose-modifying factors fk are to be determined. 
In addition modifying factors exp(g f c) are assigned to the different survival curves. 
These factors correspond to vertical shifts gk, i.e., to shifts in the logarithm 
of survival; they account for differences in the plating efficiency between experi-
ments that lead to the individual survival curves. 
fx may be set equal to 1, and g, may be set equal to 0. Furthermore, the 
values gk have to be equal for those survival curves that share the same controls. 
This can be accounted for by stating appropriate ranges for the variables, by 
adding equations as additional constraints, or by minor modifications of the for-
mulas given below. 
The least-squares condition provides the equation for the economical function 
<f)(Tu . . . , r v , / i , . . . , A , g i , 
= 1 (ttk + gk - (1 - Pik)THik - pikTnik+l)2 = Min (A18) 
with 
nik = In t (A-D i J f c /A) , 
pik = Frac( / f c -D*/A). 
Int(-) designates the closest integer value below or equal to / f r -D / A 7A, and Frac(-) 
designates the remaining fractional part offk-DiklA. 
The partial derivatives of the economical function are 
d<t> 
— = - Z i 2(1 - pik)(tik + gk - (1 - pik)THtk - pikTnik+l) 
- I2 2pik(tik + gk - (1 - pik)T„ik - pikTlljk+l), (A20) 
Sum 1 extends over all i,k with nik = v, 
Sum 2 extends over all i,k with nik + 1 = v. 
The partial derivatives d$ldTv have discontinuities wheneverf k-D i k is a multiple 
of A, i.e., iffk'Dik lies on a grid point. However, this has not caused difficulties 
with the convergence of the optimization algorithms. 
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dcb '* 
- y = l 2Dik/MTt,r - J n / / . + 1 ) 
x (tik + gk - (1 - pik)Tntk - PikT„.k+l), k = 1, . . . , 
, - « - , . > r , , - , . i v , ) . * * . 
The constraints are 
C„ = J„ - 2 T , + l + Tv+2 < 0, i ; = 1, . . . , N - 2. (A22) 
The partial derivatives of the constraints are 
dCJdT» = 1 for fi = v and fx = v + 2 
= - 2 f o r M = v + l , ( A 2 3 ) 
= 0 otherwise, 
i/ - 1, . . . , N - 2, /x - 1, . . . , N. 
E. Analysis of Errors 
In the conventional fitting of survival curves by analytical expressions with 
specified numbers of free parameters, one can calculate confidence ranges of the 
parameters [see, for example, (10,11)]. In the present case numerous parameters 
are estimated that are coupled by constraints. It is therefore uncertain whether 
an effective number of free parameters can be assigned to the fitting procedure, 
or whether the concept of free parameters is applicable at all. I t is possible, how-
ever, to derive confidence intervals for the dose-modifying factors. Such con-
fidence intervals are given in Table I ; their derivation wil l be considered in the 
following. 
Assume that a sufficiently large number of survival experiments are fitted simul-
taneously. The resulting shape of the survival curve wil l then not substantially 
change i f the fit is performed with the exclusion of one of the experiments. Within 
this approximation it is then justifiable to disregard the correlation between the 
estimated dose-modifying factorfk for one experiment and the estimated shape of 
the survival curve. The estimated value fk is associated with the least sum of 
squares <f>k for curve k. The terminal points of the 95% confidence range of fk 
correspond then to increased values qjk + A$ that are determined according to 
the Fisher distribution (10, 11): 
A(/> = (t>k-M/(N - M)F(M, N - M, a). (A24) 
In the present case M = 1 since one deals with only one free parameter fk. N 
is the number of data points for the experiment k (excluding the control). The 
statistical level a is, in the present calculation, set equal to 95%. 
A more rigorous analysis includes not only the horizontal shift fk, but also 
the vertical shift factor. The formula is then slightly modified. In the present 
case the vertical shift factors are close to unity, and their influence can be neglected. 
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In fact, both methods of calculation lead to nearly the same numerical values, 
and the simpler method is therefore presented. 
Equation (A24) serves to determine the critical values <j>k + A0 of the sum 
of squares. The functional dependence between fk and the sum of squares is 
evaluated numerically for each of the survival curves; this leads to the confidence 
ranges given in Table I . 
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